While the lipid-lowering effects were similar in both treatments , the counts of circulating CD34 + KDR+EPC s were significantly increased ( from 0.0210.015 to 0.0540.044 % of gated mononuclear cells , P < 0.05 ) only by pitavastatin treatment .